Kestra Medical Technologies (KMTS) Free Cash Flow (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Free Cash Flow data on file, last reported at $6.1 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 125.7% year-over-year to $6.1 million in Q2 2026; TTM through Apr 2026 was -$82.1 million, a 3.32% decrease from a year earlier, with the FY2026 full-year figure at -$82.1 million, down 3.32% from the prior year.
• Free Cash Flow for Q2 2026 stood at $6.1 million, up from -$28.2 million in the prior quarter.
• Over the last five years, Free Cash Flow for KMTS reached as high as $6.1 million in Q2 2026 and fell as low as -$33.8 million in Q4 2025.
• Historically, Free Cash Flow has averaged -$18.7 million across 3 years, with a median of -$23.7 million in 2025.
• Across the five-year window, Free Cash Flow slumped 246.6% in 2025 and surged 125.7% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$29.6 million in 2024, then retreated by 14.33% to -$33.8 million in 2025, then soared by 118.04% to $6.1 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $6.1 million in Q2 2026, -$28.2 million in Q1 2026, and -$33.8 million in Q4 2025.